SANARA MEDTECH INC. - COMMON STOCK

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

21 янв 2025 16:10:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

21 янв 2025 16:08:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

21 янв 2025 16:05:00 Источник Nasdaq GlobeNewswire

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

25 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Reports Third Quarter 2024 Results

12 ноя 2024 16:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

31 окт 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Changes to Its Board of Directors

07 окт 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Second Quarter 2024 Results

12 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

30 июл 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces First Quarter 2024 Results

13 май 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

29 апр 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces $55 Million Debt Facility

18 апр 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

05 апр 2024 09:00:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

25 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

13 мар 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023

22 фев 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides

03 янв 2024 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing

30 ноя 2023 09:15:00 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter 2023 Results

13 ноя 2023 16:05:01 Источник Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

30 окт 2023 09:15:00 Источник Nasdaq GlobeNewswire